{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":15,"n_cols":5,"rows_kept":15,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[9,2,9,3],[10,2,10,3],[12,2,12,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910897782903321"]
[null,null,"Autore",null,"Karakas Zeynep"]
[null,null,"Titolo",null,"Cancer : from Genomics to Pharmaceutics"]
[null,null,"Pubbl/distr/stampa",null,"Istanbul, Turkiye : , : Istanbul University Press, , 2024"]
[{"$nulls":4},"©2024"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (311 pages)"]
[null,null,"Soggetti",null,"Cancer - Genetic aspects"]
[{"$nulls":4},"Cancer - Molecular aspects"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"FOREWORD -- PREFACE -- ACKNOWLEDGEMENTS -- [-5pt][0.3ex] NEW GENOMIC ERA: WHAT WE HAVE LEARNED FROM THE CANCER GENOME?[0.2ex] Eda SUN, Müge SAYİTOĞLU  -- [-5pt][0.3ex] CANCER EVOLUTION: FROM MULTISTEP CARCINOGENESIS TO CHROMOTHRIPSIS[0.2ex] Khusan KHODZHAEV, Özden HATIRNAZ  -- [-5pt][0.3ex] EXOSOMES IN CANCER DEVELOPMENT AND METASTASIS[0.2ex] Merve Çiğdem ÖZGEL, Şeref Buğra TUNÇER  -- [-5pt][0.3ex] METHYLATION BIOMARKERS AND LIQUID BIOPSY STUDIES IN CANCER[0.2ex] Seval TURNA, Semra DEMOKAN  -- [-5pt][0.3ex] THE ROLE OF MIRNAS IN CONTROL OF K-RAS GENE EXPRESSION[0.2ex] Büşra KURT GÜLTAŞLAR, Ebru Esin YÖRÜKER  -- [-5pt][0.3ex] GERMLINE PREDISPOSITION TO CHILDHOOD CANCERS[0.2ex] Tuğçe SUDUTAN, Yücel ERBİLGİN  -- [-5pt][0.3ex] BIG DATA / MULTIOMIC APPROACHES IN CANCER RESEARCH[0.2ex] Seda SÜSGÜN, Barış SALMAN, Sibel Aylin UĞUR İŞERİ  -- [-5pt][0.3ex] NEW THERAPEUTIC APPROACHES IN GENOME[0.2ex] İldeniz USLU- BIÇAK, Büşra YAŞA-ÇEVİK, Selçuk SÖZER TOKDEMİR  -- [-5pt][0.3ex] TARGETING STRATEGIES WITH NEW DRUG DELIVERY SYSTEMS IN CANCER THERAPY[0.2ex] Yavuz Selim ÇELİK, Burcu MESUT, Yıldız ÖZSOY  -- [-5pt][0.3ex] CURRENT ADVANCES IN MEDICINAL CHEMISTRY OF ANTICANCER AGENTS[0.2ex] Efe Doğukan DİNCEL, Nuray ULUSOY GÜZELDEMİRCİ  -- [-5pt][0.3ex] THE ROLE OF PHARMACOGENOMICS IN CHEMOTHERAPEUTIC SUSCEPTIBILITY AND TOXICITY[0.2ex] Özge Sultan ZENGİN, Mahmoud ABUDAYYAK, Gül ÖZHAN"]
[null,null,null,"Sommario/riassunto","This book, edited by Zeynep Karakaş, Meryem Sedef Erdal, Müge "]
[{"$nulls":4},"Sayitoğlu, and Merva Soluk Tekkeşin, provides a comprehensive exploration of the latest advancements in cancer research. It focuses on the intersection of genomics and pharmaceutics, covering topics such as cancer evolution, genomic profiling, exosome roles in metastasis, methylation biomarkers, and therapeutic strategies. The book highlights the integration of big data and multiomic approaches to better understand cancer mechanisms, improve targeted therapies, and advance personalized medicine. Designed for researchers, clinicians, and students, it aims to serve as an authoritative resource on cutting-edge developments in cancer genomics and treatment innovations."]